Contact:
T: +44 (0)207 186 8500
E: drugsafety@shieldtx.com.
(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 GBX | -6.06% | +14.81% | -76.87% |
04-30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
04-30 | Transcript : Shield Therapeutics plc, 2023 Earnings Call, Apr 30, 2024 |
Contact:
T: +44 (0)207 186 8500
E: drugsafety@shieldtx.com.
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-76.87% | 16.12M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |